Sounds for Sleep Study in Patients Suffering From Moderate to Severe Insomnia
NCT ID: NCT06021795
Last Updated: 2025-01-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24 participants
INTERVENTIONAL
2023-07-01
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pilot Study Comparing the Effectiveness of Two Different Methods of Acoustic Stimulation
NCT03600194
Establish a National Registry of REM Sleep Behavior Disorder
NCT03671798
Broadband Sound and Sleep
NCT05774977
Metabolic and Cognitive Consequences of Noise-induced Sleep Disturbance
NCT05319262
Pharmacological and Behavioral Treatment of Insomnia
NCT00005753
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Treatment using a customized sound audio track delivered via standard commercially available bone conduction headsets
Sound Treatment
Customized sound audio track delivered via standard commercially available bone conduction headset
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sound Treatment
Customized sound audio track delivered via standard commercially available bone conduction headset
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Meets DSM 5 criteria for insomnia disorder
* Insomnia Severity Index (ISI) of 15 - 28
Exclusion Criteria
* Diagnosis of any autoimmune disorder or any medical or sleep disorder that could affect sleep
* Pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Third Wave Therapeutics
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elan Hekier, MD
Role: PRINCIPAL_INVESTIGATOR
San Francisco Otolaryngology Medical Group
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
San Francisco Otolaryngology Medical Group
San Francisco, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CP-006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.